Nabriva Therapeutics PLC (NBRVF)

[realfast95]

Nabriva Therapeutics Prices Public Offering of 18.18M Ordinary Shares @$2.75/Share
3:57 am ET July 27, 2018 (Benzinga) Print

Nabriva Therapeutics plc (NASDAQ:NBRV) announced the pricing of its underwritten public offering of 18,181,818 ordinary shares at a public offering price of $2.75 per share. In addition, Nabriva Therapeutics has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,727,272 ordinary shares at the public offering price, less the underwriting discounts and commissions. All of the ordinary shares in the offering are to be sold by Nabriva Therapeutics.

The offering is expected to close on or about July 31, 2018, subject to customary closing conditions. Morgan Stanley is acting as sole book-running manager for the offering, Needham & Company, SunTrust Robinson Humphrey, and Wedbush PacGrow are acting as lead managers for the offering and Northland Capital Markets is acting as a manager for the offering.